Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis
A patient with severe autoimmune pneumonitis from immune checkpoint inhibitor therapy for metastatic melanoma had improved clinical and radiographic clearance of the pneumonitis associated with treatment with inhaled vasoactive intestinal peptide.
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2020-06, Vol.382 (26), p.2573-2574 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2574 |
|---|---|
| container_issue | 26 |
| container_start_page | 2573 |
| container_title | The New England journal of medicine |
| container_volume | 382 |
| creator | Frye, Björn C Meiss, Frank von Bubnoff, Dagmar Zissel, Gernot Müller-Quernheim, Joachim |
| description | A patient with severe autoimmune pneumonitis from immune checkpoint inhibitor therapy for metastatic melanoma had improved clinical and radiographic clearance of the pneumonitis associated with treatment with inhaled vasoactive intestinal peptide. |
| doi_str_mv | 10.1056/NEJMc2000343 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2417025450</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2417025450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c330t-24fb1fdeb5fb1b22c1adf1a986ad5bf165c4376986878c7c068f295c934c452d3</originalsourceid><addsrcrecordid>eNpt0MtKAzEYBeAgCtbqzgcY0KWjuc5lKaXVatUu1G3I5EJTO8k4yQjufAff0CcxUhcuXB1--Pg5HACOETxHkBUX99ObO4khhISSHTBCjJCcUljsghGEuMppWZN9cBDCOhmIaD0Ct88ieCGjfdPZ3EUdonViky11F63SmXXZZKXlS-etiwmsbGOj778-PudODVKrbOn00Hpnow2HYM-ITdBHvzkGT7Pp4-Q6XzxczSeXi1wSAmOOqWmQUbphKRuMJRLKIFFXhVCsMahgkpKySHdVVrKUsKgMrpmsCZWUYUXG4GT7t-v965Aq87Uf-lQ7cExRCTGjDCZ1tlWy9yH02vCut63o3zmC_Gcu_neuxE-3vG0Dd3rd_s--Ab5baOY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417025450</pqid></control><display><type>article</type><title>Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis</title><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Frye, Björn C ; Meiss, Frank ; von Bubnoff, Dagmar ; Zissel, Gernot ; Müller-Quernheim, Joachim</creator><creatorcontrib>Frye, Björn C ; Meiss, Frank ; von Bubnoff, Dagmar ; Zissel, Gernot ; Müller-Quernheim, Joachim</creatorcontrib><description>A patient with severe autoimmune pneumonitis from immune checkpoint inhibitor therapy for metastatic melanoma had improved clinical and radiographic clearance of the pneumonitis associated with treatment with inhaled vasoactive intestinal peptide.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMc2000343</identifier><language>eng</language><publisher>Boston: Massachusetts Medical Society</publisher><subject>Immune checkpoint inhibitors ; Immune clearance ; Intestine ; Lymphocytes ; Melanoma ; Metastases ; Peptides ; Pneumonitis ; Sarcoidosis ; Vasoactive agents ; Vasoactive intestinal peptide</subject><ispartof>The New England journal of medicine, 2020-06, Vol.382 (26), p.2573-2574</ispartof><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c330t-24fb1fdeb5fb1b22c1adf1a986ad5bf165c4376986878c7c068f295c934c452d3</citedby><cites>FETCH-LOGICAL-c330t-24fb1fdeb5fb1b22c1adf1a986ad5bf165c4376986878c7c068f295c934c452d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2000343$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2417025450?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,2757,2758,26101,27922,27923,52380,54062,64383,64387,72239</link.rule.ids></links><search><creatorcontrib>Frye, Björn C</creatorcontrib><creatorcontrib>Meiss, Frank</creatorcontrib><creatorcontrib>von Bubnoff, Dagmar</creatorcontrib><creatorcontrib>Zissel, Gernot</creatorcontrib><creatorcontrib>Müller-Quernheim, Joachim</creatorcontrib><title>Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis</title><title>The New England journal of medicine</title><description>A patient with severe autoimmune pneumonitis from immune checkpoint inhibitor therapy for metastatic melanoma had improved clinical and radiographic clearance of the pneumonitis associated with treatment with inhaled vasoactive intestinal peptide.</description><subject>Immune checkpoint inhibitors</subject><subject>Immune clearance</subject><subject>Intestine</subject><subject>Lymphocytes</subject><subject>Melanoma</subject><subject>Metastases</subject><subject>Peptides</subject><subject>Pneumonitis</subject><subject>Sarcoidosis</subject><subject>Vasoactive agents</subject><subject>Vasoactive intestinal peptide</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0MtKAzEYBeAgCtbqzgcY0KWjuc5lKaXVatUu1G3I5EJTO8k4yQjufAff0CcxUhcuXB1--Pg5HACOETxHkBUX99ObO4khhISSHTBCjJCcUljsghGEuMppWZN9cBDCOhmIaD0Ct88ieCGjfdPZ3EUdonViky11F63SmXXZZKXlS-etiwmsbGOj778-PudODVKrbOn00Hpnow2HYM-ITdBHvzkGT7Pp4-Q6XzxczSeXi1wSAmOOqWmQUbphKRuMJRLKIFFXhVCsMahgkpKySHdVVrKUsKgMrpmsCZWUYUXG4GT7t-v965Aq87Uf-lQ7cExRCTGjDCZ1tlWy9yH02vCut63o3zmC_Gcu_neuxE-3vG0Dd3rd_s--Ab5baOY</recordid><startdate>20200625</startdate><enddate>20200625</enddate><creator>Frye, Björn C</creator><creator>Meiss, Frank</creator><creator>von Bubnoff, Dagmar</creator><creator>Zissel, Gernot</creator><creator>Müller-Quernheim, Joachim</creator><general>Massachusetts Medical Society</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20200625</creationdate><title>Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis</title><author>Frye, Björn C ; Meiss, Frank ; von Bubnoff, Dagmar ; Zissel, Gernot ; Müller-Quernheim, Joachim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c330t-24fb1fdeb5fb1b22c1adf1a986ad5bf165c4376986878c7c068f295c934c452d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Immune checkpoint inhibitors</topic><topic>Immune clearance</topic><topic>Intestine</topic><topic>Lymphocytes</topic><topic>Melanoma</topic><topic>Metastases</topic><topic>Peptides</topic><topic>Pneumonitis</topic><topic>Sarcoidosis</topic><topic>Vasoactive agents</topic><topic>Vasoactive intestinal peptide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frye, Björn C</creatorcontrib><creatorcontrib>Meiss, Frank</creatorcontrib><creatorcontrib>von Bubnoff, Dagmar</creatorcontrib><creatorcontrib>Zissel, Gernot</creatorcontrib><creatorcontrib>Müller-Quernheim, Joachim</creatorcontrib><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frye, Björn C</au><au>Meiss, Frank</au><au>von Bubnoff, Dagmar</au><au>Zissel, Gernot</au><au>Müller-Quernheim, Joachim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis</atitle><jtitle>The New England journal of medicine</jtitle><date>2020-06-25</date><risdate>2020</risdate><volume>382</volume><issue>26</issue><spage>2573</spage><epage>2574</epage><pages>2573-2574</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>A patient with severe autoimmune pneumonitis from immune checkpoint inhibitor therapy for metastatic melanoma had improved clinical and radiographic clearance of the pneumonitis associated with treatment with inhaled vasoactive intestinal peptide.</abstract><cop>Boston</cop><pub>Massachusetts Medical Society</pub><doi>10.1056/NEJMc2000343</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2020-06, Vol.382 (26), p.2573-2574 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_journals_2417025450 |
| source | EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
| subjects | Immune checkpoint inhibitors Immune clearance Intestine Lymphocytes Melanoma Metastases Peptides Pneumonitis Sarcoidosis Vasoactive agents Vasoactive intestinal peptide |
| title | Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T10%3A47%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vasoactive%20Intestinal%20Peptide%20in%20Checkpoint%20Inhibitor%E2%80%93Induced%20Pneumonitis&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Frye,%20Bj%C3%B6rn%20C&rft.date=2020-06-25&rft.volume=382&rft.issue=26&rft.spage=2573&rft.epage=2574&rft.pages=2573-2574&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMc2000343&rft_dat=%3Cproquest_cross%3E2417025450%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2417025450&rft_id=info:pmid/&rfr_iscdi=true |